Australian Cancer Council’s main objective is to reduce cancer’s impact and improve the wellbeing.Their goals include fighting disparities, improving health outcomes, supporting scientific advancements, and advising the government. A critical focus of their work is the Australian Cancer Plan along with supporting the priority populations for exemplary cancer outcomes.
2. Recommendation:
In this data analysis, we researched how delays in detecting tumor size can be detrimental to the timely treatment of cancer patients. We recommend to the Australian Cancer Council that early detection of tumor size in breast cancer is crucial for enabling prompt and adequate treatment planning
3. Evidence
3.1 Tumor Size Distribution across Cancer Stages
This boxplot illustrates how tumor size varies across different stages of breast cancer (IIA, IIB, IIIA, IIIB)
The plot shows a clear increasing trend in tumor size as the stage increase from IIA to IIIB. Lower stages such as IIA and IIB tend to have smaller tumor sizes, while higher stages like IIIA and IIIB has larger tumors
3.2 Scatterplot: Tumor Size vs Survival Months
The scatter plot below shows the relationship between tumor size and survival months, coloured by cancer stage (IIA to IIIB)
Code
library(dplyr)library(ggplot2)library(readr)library(plotly)library(reactable)library(kableExtra)library(gt)Data2 <-read.csv("breast_cancer (1).csv")Data2 <- Data2 %>%filter(X6th.Stage !="IIIC")ggplot(Data2, aes(x = Tumor.Size, y = Survival.Months, color = X6th.Stage)) +geom_point(size =2, alpha =0.6) +geom_smooth(method ="lm", se =FALSE, color ="red", linetype ="dashed") +scale_color_manual(values =c("IIA"="palevioletred1","IIB"="deepskyblue1","IIIA"="khaki1","IIIB"="magenta1" ) ) +labs(title ="Tumor Size vs Survival Months by 6th Stage",x ="Tumor Size (mm)",y ="Survival Months",color ="6th Stage" ) +theme_minimal()
[1] 0.0001472146
Visual Interpretation:
The scatter plot shows that smaller tumor sizes (<50 mm) and cancer stages (IIA, IIB) are typically associated with longer survival months . On the other hand, larger tumors (>50 mm) and further stages (IIIA, IIIB) typically associate with shorter survival months (less than 60 months)
Correlation Test:
The correlation test (p = 0.0001) shows a weak but significant negative relationship, large tumors are tied to have short survival emphasizing the need for early detection
Tumor size (\(p = 1.66 \times 10^{-6}\)), estrogen status (\(p = 1.29 \times 10^{-15}\)), and their interaction (\(p = 3.21 \times 10^{-5}\)) all have a significant effect on survival months. Survival decreases with larger tumors and negative estrogen status, and the impact of tumor size varies by estrogen status.
Conclusion:
Tumor size increases with stage, reducing survival rates, while estrogen status significantly affects outcomes.All these key findings highlights the importance of timely detection of tumour size hence plan the treatment suitably.
Limitations
Incomplete data
– Some patient records may lack information
Independent Analysis
– The analysis is based on specific dataset, it may not be completely relatable to all individuals
I did this analysis with honesty, making sure to interpret the data transparently and with respect. I remained unbiased and aware of how it could affect things, dedicated to using the statistics to help make important and ethical choices in cancer treatment.
This AI tool helped me how to manually fill colors in barplots and use appropriate statistical tests it is found in evidence section. Additionally, it helped me figure out my errors while rendering.
6. Acknowledgement
Drop in -
9/05/2025
cleared few of my doubts with tutor regarding word count,formatting and the variables which would give best graphical visualization according to my idea.
13/05/2025
Tutor suggested me to use scatterplot instead of stacked barplot for better visual analysis of my idea ED - post - ED Post 1